SingHealth Institutions will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.
First established in 2012, the Pancreas Transplant program is a collaborative effort with the National University Hospital Singapore to establish pancreas transplantation in Singapore. This provides an additional treatment option for patients who suffer from Type 1 diabetes. The first simultaneous kidney and pancreas transplant in Singapore was successfully carried out in September 2012.
The main objectives of pancreas transplant are to render Type 1 diabetes patients’ insulin-independent, to improve quality of life, and to reduce long-term diabetic complications. It has been shown to prolong survival in patients with diabetes and renal failure. Pancreas transplant has been performed for over 4 decades and is a well-established procedure in diabetic patients.
To date, more than 30,000 pancreas transplants have been reported to the International Pancreas Transplant Registry (IPTR), with more than 22,000 from the USA and more than 8,000 from outside the USA. The 1-year graft survival rates now exceed 80%, and the 1-year patient survival rates are 95%. The 3-year patient survival rates exceed 90%, and the 3-year pancreas graft survival is about 80% for simultaneous pancreas-kidney recipients. The 5-year pancreas graft survival rate is 72% and patient survival rate is 86%, compared to a 5-year patient survival of 38% without transplant in Singapore.
The pancreas plays a key role in regulating blood sugar levels by producing insulin. In patients with Type 1 diabetes, the pancreas is unable to produce insulin, leading to lifelong insulin dependence.
A pancreas transplant aims to restore natural insulin production, helping patients achieve better glucose control, improve quality of life, and reduce diabetes-related complications.
When combined with a kidney transplant, the procedure also addresses kidney failure caused by long-term diabetes, allowing both endocrine (pancreas) and renal (kidney) functions to be restored.
Pancreas transplant is performed in three possible scenarios:
Eligibility criteria:
Patients are deemed suitable if they are below 55 years old and have:
Potential SPK recipients must demonstrate Type 1 diabetic physiology and qualify for kidney transplant independently (i.e. be on dialysis).
For pancreas transplant alone, indications include hypoglycemic unawareness, frequent or severe hypoglycemic attacks, and may be performed as PTA or PAK.
Organ allocation in Singapore:
Pancreas transplant is almost always performed using cadaveric donor organs. Under current regulations, pancreas donation is governed by the Medical Therapy Education and Research Act (MTERA).
Patients requiring simultaneous pancreas-kidney transplant are prioritised due to their higher mortality risk without transplant, which may result in shorter waiting times compared to patients requiring kidney transplant alone.
We care for patients with:
Our Services Include:
Location
SingHealth Duke-NUS Transplant Centre
National Heart Centre Singapore, Level 7
5 Hospital Drive
Singapore 169609
Email:
sd.transplant.centre@singhealth.com.sg
Contact:
+65 6312 2720
Keep Healthy With
© 2026 Singapore Health Services Pte Ltd. All Rights Reserved.